Treatment Outcomes of Low-grade Lymphoma of the Orbit.
Holloway CL, Pickles T, Croteau NS, Wai ES.
Clin Oncol (R Coll Radiol). 2022 Jul;34(7):e298-e304. doi: 10.1016/j.clon.2022.01.042. Epub 2022 Feb 21.
Natural Killer T-Cell Lymphoma of the Orbit: An Evidence-Based Approach.
Jiménez-Pérez JC, Yoon MK.
Semin Ophthalmol. 2017;32(1):116-124. doi: 10.1080/08820538.2016.1228405. Epub 2016 Oct 14.
Primary diffuse large B-cell lymphoma of orbit: A population-based analysis.
Chen YQ, Yue ZF, Chen SN, Tong F, Yang WH, Wei RL.
Front Med (Lausanne). 2022 Sep 15;9:990538. doi: 10.3389/fmed.2022.990538. eCollection 2022.
Orbital lymphoma.
Olsen TG, Heegaard S.
Surv Ophthalmol. 2019 Jan-Feb;64(1):45-66. doi: 10.1016/j.survophthal.2018.08.002. Epub 2018 Aug 23.
The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease.
Takahira M, Goto H, Azumi A.
Jpn J Ophthalmol. 2024 Jul;68(4):293-301. doi: 10.1007/s10384-024-01072-4. Epub 2024 Jul 22.
Lymphoma and inflammatory disorders presenting in the orbit- a comparison of characteristics from a 10-year series in a tertiary hospital.
Hunt S, Pereni I, Ford R, Garrott H.
Orbit. 2022 Jun;41(3):315-320. doi: 10.1080/01676830.2021.1892771. Epub 2021 Feb 28.
[IgG4-related disease].
Pitz S.
Ophthalmologe. 2021 Aug;118(8):787-793. doi: 10.1007/s00347-021-01448-8. Epub 2021 Jul 1.
Ocular adnexal lymphoma - a retrospective study and review of the literature.
Boltezar L, Strbac D, Pizem J, Hawlina G.
Radiol Oncol. 2024 Sep 15;58(3):416-424. doi: 10.2478/raon-2024-0048. eCollection 2024 Sep 1.
Lymphoproliferative disease of the orbit.
Bernardini FP, Bazzan M.
Curr Opin Ophthalmol. 2007 Sep;18(5):398-401. doi: 10.1097/ICU.0b013e3282be8fbb.
Orbital lymphoma: role of radiation.
Yadav BS, Sharma SC.
Indian J Ophthalmol. 2009 Mar-Apr;57(2):91-7. doi: 10.4103/0301-4738.44516.
